Search

Worldwide, the number of people with glaucoma is expected to reach 60 million by 2010 and 80 million by 2020, with approximately 75% of those cases due to open-angle glaucoma [...]

The article discusses the techniques for monitoring the compliance of patients to medical instructions. A study on compliance made by researchers from Wills Eye Hospital showed that patients comply more with medical therapy if they had one bottle with them than multiple bottles. Forgetfulness, being physically away from medication, and frequency of medication were some of the reasons which made patients fail to comply.

Discusses the treatment for complications resulting from glaucoma. Factors that favor the urgent treatment of bleb infection; Options for intervention.

Provides information on the discussion on which agents are best as first-line glaucoma therapy at the Glaucoma Symposium of the American Academy of Ophthalmology. Types of beta-blockers use for the treatment of glaucoma; Purpose of using alpha-agonists; Dosage of prostaglandin given for the treatment of glaucoma.

The article discusses several devices evaluated by Dr. L. Jay Katz of Wills Eye Hospital in Philadelphia, Pennsylvania for ambulatory intraocular pressure measurement for glaucoma management. Topics mentioned include a home tonometry device developed by a Finland company, two different versions of ambulatory IOP systems being developed by medical device firm Implandata Ophthalmic Products GmbH, and wireless sensor systems from medical device company AcuMEMS.

The article focuses on the efficacy of selective laser trabeculoplasty (SLT) as the initial therapy in the treatment of open-angle glaucoma in the U.S. According to sources, patients treated with SLT was comparable with that in the patients treated medically, due to lesser intraocular pressure. Furthermore, other advantages of SLT include fewer side effects and less expense for patients.

The article focuses on the significance of compliance in glaucoma therapy in the United States, citing the need for physicians to encourage patients to keep on track with medication. Physicians must try to simplify the regimen to ensure compliance by patients, specifically the elderly. Key factors that may hinder compliance include the absence of symptoms among patients and the emergence of side effects from therapy.

Reports on the effectiveness of the topical formulation of timolol maleate ophthalmic solution to provide ocular penetration as a result of the addition of potassium sorbate. Potential of potassium sorbate to increase the ocular penetration of timolol maleate; Advantage of prescribing a beta-blocker for use in the morning; Side effects associated with the topical solution.

Reports on the study indicating the potential of the fixed combination of dorzolamide hydrochloride-timolol maleate and the unfixed combination of latanaprost and timolol to reduce inherent optical property (IOP) to a similar degree in patients with glaucoma. Mean reduction in both treatments; Efficacy of monotherapy with latanoprost in reducing IOP; Average baseline IOP in patients who began randomized treatment with the fixed combination.

Discusses the effectiveness of trabeculectomy for treating refractory glaucoma. Trials which have proven the effectiveness of the procedure; Limitations of other surgical procedures for refractive glaucoma.

Provides information on neuroprotection, a technique in cell death prevention. Application of neuroprotection in preventing glaucomatous damage; Purpose of neuroprotection in glaucoma; Mechanism of action of some neuroprotective agents.